Ethis Communications, Inc.
The Ocular Surface (www.theocularsurface.com)
“The Ocular Surface has rapidly garnered a remarkable amount of industry attention. It’s a credit to the caliber of the scientists and clinicians who are submitting to this journal,” added Founding Editor Michael A. Lemp, MD, clinical professor of ophthalmology at Georgetown and George Washington Universities in Washington, D.C.
Since 2003, The Ocular Surface has been providing timely review articles derived from the growing body of knowledge concerning the ocular surface. Conditions such as dry eye disease, inflammation, infection, allergy, and ocular surface surgery are covered in depth, as are developments in therapeutics, clinical trials, and basic science. Coverage also includes FDA trials and filings, drugs in development, patents, new products, and profiles of individuals and institutions working in the field. The Ocular Surface is designed to make information easily accessible to clinicians and investigators;
A global publication, The Ocular Surface has a vast readership that includes ophthalmologists and optometrists in clinical practice, researchers in academic and industry settings, clinical scientists, and members of the ophthalmic pharmaceutical industry.
Photo:
http://www.prlog.org/
